Zeria Pharmaceutical (Japan)

323 papers and 4.8k indexed citations i.

About

In recent decades, authors affiliated with Zeria Pharmaceutical (Japan) have published 323 papers, which have received a total of 4.8k indexed citations. Scholars at this organization have produced 74 papers in Molecular Biology, 51 papers in Surgery and 48 papers in Oncology on the topics of Helicobacter pylori-related gastroenterology studies (31 papers), Biochemical effects in animals (21 papers) and Drug Transport and Resistance Mechanisms (19 papers). Their work is cited by papers focused on Molecular Biology (1.2k citations), Surgery (1.1k citations) and Gastroenterology (713 citations). Authors at Zeria Pharmaceutical (Japan) collaborate with scholars in Japan, United Kingdom and United States and have published in prestigious journals including Journal of Biological Chemistry, Journal of Clinical Investigation and Blood. Some of Zeria Pharmaceutical (Japan)'s most productive authors include Jan Tack, Patricia E. Burger, IKUO MORIGUCHI, Shuichi Hirono, Hiroyuki Hirano, Kei Matsueda, Mineo Takei, Izumi Nakagome, Michio Hongo and Hiroki Kato.

In The Last Decade

Fields of papers published by authors at Zeria Pharmaceutical (Japan)

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers affiliated with Zeria Pharmaceutical (Japan) at the time of their publication. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers affiliated with Zeria Pharmaceutical (Japan) at the time of their publication.

Countries citing scholars working at Zeria Pharmaceutical (Japan)

Since Specialization
Citations

This map shows the geographic impact of research produced by authors working at Zeria Pharmaceutical (Japan). It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers produced at Zeria Pharmaceutical (Japan) with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zeria Pharmaceutical (Japan) more than expected).

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar’s output or impact.

Explore institutions with similar magnitude of impact

Rankless by CCL
2025